NIU Consulting

Executive Summary

NIU Consulting is an Italian consultancy founded in 2018 that provides regulatory, preclinical, and biological safety assessment services for medical device and medtech companies. The firm positions itself as an extension of its clients' teams, guiding them through the complex journey of bringing innovative and high-risk medical devices to market—from design and testing to certification and post-market surveillance. With deep expertise in EU MDR compliance and biological evaluations, NIU Consulting addresses a critical need for specialized support in the increasingly stringent regulatory environment. As medical device manufacturers face tighter deadlines and evolving standards, especially under the EU Medical Device Regulation (MDR), NIU Consulting's tailored services help reduce time-to-market and mitigate compliance risks. The company's focus on complex, high-risk devices positions it well in a niche but growing market. While private and lean, NIU Consulting's business model is scalable and resilient, relying on recurring project-based engagements and long-term client relationships. The firm's ability to adapt to regulatory changes and expand its service offerings will be key drivers of future growth.

Upcoming Catalysts (preview)

• Q2 2026EU MDR Transition Deadline (May 2026) Driving Demand for Certification Support80% success
• Q3 2026Expansion into Biological Evaluation Services per ISO 10993 Updates70% success
• Q2 2026Partnership with Notified Bodies for Streamlined Approval Process60% success